286 related articles for article (PubMed ID: 29127844)
1. The role of A-to-I RNA editing in cancer development.
Xu X; Wang Y; Liang H
Curr Opin Genet Dev; 2018 Feb; 48():51-56. PubMed ID: 29127844
[TBL] [Abstract][Full Text] [Related]
2. All I's on the RADAR: role of ADAR in gene regulation.
Shevchenko G; Morris KV
FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
[TBL] [Abstract][Full Text] [Related]
3. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
Tassinari V; Cesarini V; Silvestris DA; Gallo A
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
[TBL] [Abstract][Full Text] [Related]
4. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.
Walkley CR; Li JB
Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589
[TBL] [Abstract][Full Text] [Related]
5. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
Wang Y; Liang H
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-to-Inosine RNA Editing in Health and Disease.
Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
[TBL] [Abstract][Full Text] [Related]
7. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
Han L; Diao L; Yu S; Xu X; Li J; Zhang R; Yang Y; Werner HMJ; Eterovic AK; Yuan Y; Li J; Nair N; Minelli R; Tsang YH; Cheung LWT; Jeong KJ; Roszik J; Ju Z; Woodman SE; Lu Y; Scott KL; Li JB; Mills GB; Liang H
Cancer Cell; 2015 Oct; 28(4):515-528. PubMed ID: 26439496
[TBL] [Abstract][Full Text] [Related]
8. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-to-inosine RNA editing.
Zinshteyn B; Nishikura K
Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Adenosine-to-Inosine RNA Editing in Cancer.
Gan WL; Ng L; Ng BYL; Chen L
Cancer Treat Res; 2023; 190():143-179. PubMed ID: 38113001
[TBL] [Abstract][Full Text] [Related]
11. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
12. Controlling the Editor: The Many Roles of RNA-Binding Proteins in Regulating A-to-I RNA Editing.
Washburn MC; Hundley HA
Adv Exp Med Biol; 2016; 907():189-213. PubMed ID: 27256387
[TBL] [Abstract][Full Text] [Related]
13. Proteome diversification by adenosine to inosine RNA editing.
Pullirsch D; Jantsch MF
RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-to-inosine RNA editing meets cancer.
Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
[TBL] [Abstract][Full Text] [Related]
15. Adenosine-to-inosine RNA editing in neurological development and disease.
Yang Y; Okada S; Sakurai M
RNA Biol; 2021 Jul; 18(7):999-1013. PubMed ID: 33393416
[TBL] [Abstract][Full Text] [Related]
16. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing.
Hong H; Lin JS; Chen L
Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25662729
[TBL] [Abstract][Full Text] [Related]
17. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
Deffit SN; Hundley HA
Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
[TBL] [Abstract][Full Text] [Related]
18. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
Liao Y; Jung SH; Kim T
Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
[TBL] [Abstract][Full Text] [Related]
19. A-to-I editing challenger or ally to the microRNA process.
Ohman M
Biochimie; 2007 Oct; 89(10):1171-6. PubMed ID: 17628290
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-to-Inosine RNA Editing and
Nakano M; Nakajima M
Drug Metab Dispos; 2022 May; 50(5):624-633. PubMed ID: 35152204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
